Neurological symptoms and neuronal damage markers in acute COVID‐19: Is there a correlation? A pilot study
 
Yazarlar (7)
Doç. Dr. Burç Esra ŞAHİN Kırşehir Ahi Evran Üniversitesi, Türkiye
Asuman Çelikbilek Kırşehir Ahi Evran Üniversitesi, Türkiye
Yusuf Koçak Kirsehir Ahi Evran University, Türkiye
Doç. Dr. Bilal İLANBEY Kırşehir Ahi Evran Üniversitesi, Türkiye
Dr. Öğr. Üyesi Gamze TURNA SALTOĞLU Kırşehir Ahi Evran Üniversitesi, Türkiye
Dr. Öğr. Üyesi Lokman HİZMALİ Kırşehir Ahi Evran Üniversitesi, Türkiye
Makale Türü Açık Erişim Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale)
Dergi Adı JOURNAL OF MEDICAL VIROLOGY (Q1)
Dergi ISSN 0146-6615 Wos Dergi Scopus Dergi
Dergi Tarandığı Indeksler SCI-Expanded
Makale Dili Türkçe Basım Tarihi 01-2023
Kabul Tarihi 12-04-2026 Yayınlanma Tarihi
Cilt / Sayı / Sayfa 95 / 1 / – DOI 10.1002/jmv.28240
Makale Linki https://www.ncbi.nlm.nih.gov/pmc/articles/9874781
Özet
A wide spectrum of neurological symptoms (NS) has been described in patients with COVID‐19. We examined the plasma levels of neuron‐specific enolase (NSE) and neurofilament light chain (NFL) together, as neuronal damage markers, and their relationships with clinical severity in patients with NS at acute COVID‐19. A total of 20 healthy controls and 59 patients with confirmed COVID‐19 were enrolled in this pilot prospective study. Serum NSE and NFL levels were measured by using the enzyme‐linked immunoassay method from serum samples. Serum NSE levels were found to be significantly higher in the severe group than in the nonsevere group (p = 0.034). However, serum NFL levels were similar between the control and disease groups (p > 0.05). For the mild group, serum NFL levels were significantly higher in patients with the sampling time ≥5 days than in those with the sampling time <5 days …
Anahtar Kelimeler
COVID-19 | neurofilament light chain | neurological symptoms | neuron-specific enolase | neuronal damage
BM Sürdürülebilir Kalkınma Amaçları
Atıf Sayıları
Google Scholar 14
Web of Science 11
Neurological symptoms and neuronal damage markers in acute COVID‐19: Is there a correlation? A pilot study

Paylaş